Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial

Overview of attention for article published in BMC Cancer, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Comparing the efficacy and side-effects of PDLASTA (Pegfilgrastim) with PDGRASTIM (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial https://t.co/VO3zTA5a0d #breastcancer #oncology https://t.co/7weC4x1LVr

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.